Placeholder

CSR Gets a Makeover

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Corporate social responsibility (CSR) policies have been in place for decades at most companies, but the increased social awareness of today’s consumers has stepped up the visibility of such programs. The state of the world’s economy, the ever-evolving business environment, and an overall growth in social awareness of corporate sustainability is shining a spotlight on the efforts of business entities large and small. Finding out what a company is doing in terms of CSR is easy: most policies and programs are posted online (see online bonus content for more information), and consumers now have the power to monitor and, therefore, influence how a company supports its community, operates sustainably…

Sidebar:
Organizations Join UN Global Compact to Showcase Social Responsibility
Sound bites From the Field
Elaine Cohen
is CEO of Beyond Business Ltd., which specializes in CSR consulting and sustainability reporting. For more information, visit b-yond.biz/en or email elainec@b-yond.biz.
Laura Nguyen is Senior Manager of Social Media Strategy at Intouch Solutions Inc., a digital marketing agency, servicing the ­pharmaceutical industry. For more information, visit intouchsol.com.
CSR Policies and Programs: What is Everyone Doing?
Taking Pride in CSR

Experts
Jonathan Feinstein. Positive Impact Coordinator, imc2, a full-service agency that leads clients by cultivating ­sustainable relationships ­between brands and people. For more ­information, visit imc2.com.
Art Gibson. VP, Environment, Health, Safety and Sustainability, Baxter ­International Inc., which through its ­subsidiaries, develops, manufactures, and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. For more ­information, visit baxter.com.
Patricia Hughes. Executive Director, Roche Foundation and Director, ­Corporate Relations and Contributions, Roche, a research-focused healthcare company with combined strengths in pharmaceuticals and ­diagnostics. For more information, visit roche.com or or roche-nutley.com.
Allison Hyers. VP, Recruitment and ­Resource Management, Harrison and Star, a healthcare advertising and communications agency providing ­strategic and ­creative services for pharmaceutical, biotechnology, diagnostic, and medical-device ­industries. For more information, visit hs-ideas.com.
Joe Jimenez. CEO, Novartis, a global healthcare company whose diverse portfolio spans ­innovative pharmaceuticals, generics, eye care products, vaccines and ­diagnostics, and ­consumer health ­products. For more ­information, visit novartis.com.
Julie Kampf. CEO, President and Founder, JBK Associates, an ­organization specializing in the acquisition, management, and ­development of senior-level talent across a wide spectrum of functional responsibilities and industries. For more information, visit jbkassociates.net.
Tatjana May. Chair, ­Responsibility ­Coordination Team, Shire Pharmaceuticals, a specialty biopharmaceutical company. For more information, visit shire.com.
John Spinnato. VP and General Counsel and VP of North America Corporate Social Responsibility, Sanofi-Aventis U.S., a global ­pharmaceutical company that discovers, ­develops, and distributes therapeutic ­solutions to help improve the lives of patients. For more information, visit sanofi-aventis.us.

FEEDBACK